Company Overview - InMode is a leading global provider of innovative, minimally-invasive aesthetic and wellness solutions[5] - The company has a broad radiofrequency (RF) based portfolio, including capital equipment and consumables[5] - InMode sells in 89 countries[7] - The company has 669 employees worldwide, including 297 direct sales reps and a 42 person R&D team[12] Financial Performance (Q2 2025) - Q2-2025 Revenue was $95.6 million[7] - Q2-2025 Non-GAAP Net Income was $30.1 million[7] - Q2-2025 Non-GAAP Gross Margin was 80%[7] - Q2-2025 Non-GAAP Diluted Earning per Share was $0.47[7] Technology and Solutions - InMode addresses the "Treatment Gap" with minimally-invasive technologies[20] - The company has 10 patented technologies across 11 product families[7] - Clinical studies demonstrate RFAL technology can achieve up to 40% contraction of the heated tissue volume[34] - InMode has launched multiple innovative product platforms since 2010[86]

Company Overview - InMode is a leading global provider of minimally-invasive aesthetic and wellness solutions[4] - The company has a broad radiofrequency (RF) based portfolio, including capital equipment and consumables[4] - InMode sells in 90 countries[6] - The company has 641 employees worldwide, including 281 direct sales reps[11] Q1 2025 Financial Highlights - Q1 2025 revenue was $77.9 million[6] - Q1 2025 Non-GAAP net income was $21.4 million[6] - Q1 2025 Non-GAAP gross margin was 79%[6] - Q1 2025 Non-GAAP diluted earning per share was $0.31[6] Technology and Market - InMode addresses the "Treatment Gap" between laser procedures and plastic surgery with minimally-invasive technologies[17, 18] - Clinical studies demonstrate RFAL technology can achieve up to 40% contraction of the heated tissue volume[32]